Literature DB >> 6436303

Comparison of enzyme-linked immunosorbent and indirect hemagglutination assays for determining anthrax antibodies.

A Johnson-Winegar.   

Abstract

An enzyme-linked immunosorbent assay has been established to measure anthrax antibody titers. The protective antigen component of anthrax toxin was used as the capture antigen. Two types of conjugates (protein A-horseradish peroxidase and anti-human immunoglobulin G plus immunoglobulin A plus immunoglobulin M-horseradish peroxidase) were tested. Results from enzyme-linked immunosorbent assay testing were compared with those from indirect hemagglutination titers on serum from vaccinees. The overall trend of enzyme-linked immunosorbent assay and indirect hemagglutination titers was significant. The enzyme-linked immunosorbent assay offered speed, precision, and reduced cost per test.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6436303      PMCID： PMC271329          DOI： 10.1128/jcm.20.3.357-361.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.

Authors:  M PUZISS; L C MANNING; J W LYNCH; I ABELOW; G G WRIGHT
Journal:  Appl Microbiol       Date:  1963-07

2.  Serologic testing for anthrax antibodies in workers in a goat hair processing mill.

Authors:  P S NORMAN; J G RAY; P S BRACHMAN; S A PLOTKIN; J S PAGANO
Journal:  Am J Hyg       Date:  1960-07

3.  An agar-diffusion method for titrating Bacillus anthracis immunizing antigen and its application to a study of antigen production.

Authors:  C B THORNE; F C BELTON
Journal:  J Gen Microbiol       Date:  1957-10

4.  Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen.

Authors:  G G WRIGHT; T W GREEN; R G KANODE
Journal:  J Immunol       Date:  1954-12       Impact factor: 5.422

5.  Field Evaluation of a Human Anthrax Vaccine.

Authors:  P S Brachman; H Gold; S A Plotkin; F R Fekety; M Werrin; N R Ingraham
Journal:  Am J Public Health Nations Health       Date:  1962-04

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Anthrax indirect microhemagglutination test.

Authors:  T M Buchanan; J C Feeley; P S Hayes; P S Brachman
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

8.  Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.

Authors:  M PUZISS; G G WRIGHT
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490

9.  AGAR-GEL PRECIPITIN TECHNIQUE IN ANTHRAX ANTIBODY DETERMINATIONS.

Authors:  J G RAY; P J KADULL
Journal:  Appl Microbiol       Date:  1964-07
  9 in total
  12 in total

1.  Serology and anthrax in humans, livestock and Etosha National Park wildlife.

Authors:  P C Turnbull; M Doganay; P M Lindeque; B Aygen; J McLaughlin
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

2.  Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.

Authors:  P C Turnbull; M G Broster; J A Carman; R J Manchee; J Melling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

3.  Purification of anthrax-toxin components by high-performance anion-exchange, gel-filtration and hydrophobic-interaction chromatography.

Authors:  C P Quinn; C C Shone; P C Turnbull; J Melling
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

4.  Immunogenicity and safety of four different dosing regimens of anthrax vaccine adsorbed for post-exposure prophylaxis for anthrax in adults.

Authors:  David I Bernstein; Lisa Jackson; Shital M Patel; Hana M El Sahly; Paul Spearman; Nadine Rouphael; Thomas L Rudge; Heather Hill; Johannes B Goll
Journal:  Vaccine       Date:  2014-09-17       Impact factor: 3.641

5.  Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay.

Authors:  R E Biagini; D L Sammons; J P Smith; E H Page; J E Snawder; C A F Striley; B A MacKenzie
Journal:  Occup Environ Med       Date:  2004-08       Impact factor: 4.402

Review 6.  Bacillus anthracis as an agent of bioterrorism: a review emphasizing surgical treatment.

Authors:  Charles E Binkley; Sandro Cinti; Diane M Simeone; Lisa M Colletti
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

7.  Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.

Authors:  Raymond E Biagini; Deborah L Sammons; Jerome P Smith; Barbara A MacKenzie; Cynthia A F Striley; Vera Semenova; Evelen Steward-Clark; Karen Stamey; Alison E Freeman; Conrad P Quinn; John E Snawder
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

8.  Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies.

Authors:  L C Iacono-Connors; J Novak; C Rossi; J Mangiafico; T Ksiazek
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

9.  Simultaneous and Rapid Detection of Salmonella typhi, Bacillus anthracis, and Yersinia pestis by Using Multiplex Polymerase Chain Reaction (PCR).

Authors:  Nargess Safari Foroshani; Ali Karami; Fatemeh Pourali
Journal:  Iran Red Crescent Med J       Date:  2013-11-05       Impact factor: 0.611

10.  Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.

Authors:  Conrad P Quinn; Vera A Semenova; Cheryl M Elie; Sandra Romero-Steiner; Carolyn Greene; Han Li; Karen Stamey; Evelene Steward-Clark; Daniel S Schmidt; Elizabeth Mothershed; Janet Pruckler; Stephanie Schwartz; Robert F Benson; Leta O Helsel; Patricia F Holder; Scott E Johnson; Molly Kellum; Trudy Messmer; W Lanier Thacker; Lilah Besser; Brian D Plikaytis; Thomas H Taylor; Alison E Freeman; Kelly J Wallace; Peter Dull; Jim Sejvar; Erica Bruce; Rosa Moreno; Anne Schuchat; Jairam R Lingappa; Sandra K Martin; John Walls; Melinda Bronsdon; George M Carlone; Mary Bajani-Ari; David A Ashford; David S Stephens; Bradley A Perkins
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.